BNP Paribas Financial Markets’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $96.5K | Buy |
|
|||||
|
2025
Q2 | $30K | Sell |
|
|||||
|
2025
Q1 | $133K | Buy |
|
|||||
|
2024
Q4 | $4.25K | Sell |
|
|||||
|
2024
Q3 | $263K | Sell |
|
|||||
|
2024
Q2 | $614K | Sell |
|
|||||
|
2024
Q1 | $414K | Buy |
|
|||||
|
2023
Q4 | $154K | Buy |
|
|||||
|
2023
Q3 | $95.9K | Sell |
|
|||||
|
2023
Q2 | $875K | Sell |
|
|||||
|
2023
Q1 | $1.74M | Buy |
|
|||||
|
2022
Q4 | $1.36M | Buy |
|
|||||
|
2022
Q3 | $2.14M | Buy |
|
|||||
|
2022
Q2 | $2.24M | Sell |
|
|||||
|
2022
Q1 | $3.28M | Sell |
|
|||||
|
2021
Q4 | $6.06M | Buy |
|
|||||
|
2021
Q3 | $1.48M | Sell |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2021
Q1 | $1.57M | Sell |
|
|||||
|
2020
Q4 | $2.54M | Buy |
|
|||||
|
2020
Q3 | $875K | Buy |
|
|||||
|
2020
Q2 | $465K | Sell |
|
|||||
|
2020
Q1 | $1.51M | Buy |
|
|||||
|
2019
Q4 | $604K | Buy |
|
|||||
|
2019
Q3 | $431K | Buy |
|
|||||
|
2019
Q2 | $293K | Sell |
|
|||||
|
2019
Q1 | $719K | Buy |
|
|||||
|
2018
Q4 | $86.6K | Sell |
|
|||||
|
2018
Q3 | $433K | Buy |
|
|||||
|
2018
Q2 | $238K | Sell |
|
|||||
|
2018
Q1 | $584K | Sell |
|
|||||
|
2017
Q4 | $1.6M | Buy |
|
|||||
|
2017
Q3 | $730K | Buy |
|
|||||
|
2017
Q2 | $361K | Buy |
|
|||||
|
2017
Q1 | $206K | Buy |
|
|||||
|
2016
Q4 | $210K | Buy |
|
|||||
|
2016
Q3 | $163K | Sell |
|
|||||
|
2016
Q2 | $276K | Buy |
|
|||||
|
2016
Q1 | $165K | Sell |
|
|||||
|
2015
Q4 | $241K | Sell |
|
|||||
|
2015
Q3 | $182K | Buy |
|
|||||
|
2015
Q2 | $83.2K | Buy |
|
|||||
|
2015
Q1 | $20.1K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $38.7K | Buy |
|
|||||
|
2014
Q2 | $270 | Sell |
|
|||||
|
2014
Q1 | $2.24K | Sell |
|
|||||
|
2013
Q4 | $9.15K | Buy |
|